Pioneering Paths: Genetic Testing in Pigmentary Retinal Dystrophy
Uncover how genetic testing aids in diagnosing pigmentary retinal dystrophy, guides personalized care, supports family planning, and fuels innovative research.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Pioneering Paths: Genetic Testing and Pilomatrixoma
Explore how genetic testing enhances pilomatrixoma diagnosis, informs treatment, and contributes to research, focusing on CTNNB1 gene mutations and precision medicine.
Pioneering Pathways: Genetic Testing and Pretibial Dystrophic Epidermolysis Bullosa
Genetic testing is crucial for diagnosing pretibial dystrophic epidermolysis bullosa, guiding family planning, and exploring personalized treatment options and clinical trials.
Pinpointing Primary Erythromelalgia: The Crucial Role of Genetic Testing
Unlock insights for primary erythromelalgia with genetic testing. Ensure accurate diagnosis, guide treatments, and inform families with this powerful diagnostic tool.
Primary Familial Polycythemia Due to EPO Receptor Mutation: Understanding and Managing Through Genetic Testing
Uncover primary familial polycythemia's genetic basis, diagnosis, and personalized treatments through EPO receptor mutation testing for improved patient outcomes.
Progressive Myositis Ossificans: Unraveling the Genetic Code to Combat a Constricting Condition
Explore the impact of genetic testing on progressive myositis ossificans, focusing on early diagnosis, personalized treatments, and advances in managing this rare disorder.
Pioneering Precision: Genetic Testing in Pseudohypoaldosteronism Type 2A
Genetic testing revolutionizes PHA2A diagnosis, offering early detection, personalized treatments, and family planning insights for this rare genetic disorder.
Revealing Renal Cysts and Diabetes Syndrome: The Role of Genetic Testing
Unlock the potential of genetic testing in diagnosing Renal Cysts and Diabetes Syndrome, ensuring precise identification and personalized treatment for better outcomes.